Press Releases

Bio-Tissue Launches Website to Educate on Long-Lasting Solution for Mechanical Dry Eye (MDE), aka Conjunctivochalasis (CCh)

Bio-Tissue

Miami, FL – November 12, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord-based products for unmet patient needs, announced today the launch of an educational website, www.DiscoverMDE.com , on Mechanical Dry Eye, MDE, also sometimes referred to as Conjunctivochalasis (CCh). The website features educational information, videos, testimonials and other resources for both patients and health care providers.

Bio-Tissue Founder, Pioneer in Ocular Use of Amniotic Membrane Mentors Minority Students During 2019 American Academy of Ophthalmology Meeting

Bio-Tissue

Scheffer C.G. Tseng, MD, PhD meets with underrepresented undergraduate and medical students to promote diversity in ophthalmology    Miami, FL – November 4, 2019 – Scheffer C.G. Tseng, MD, PhD, Chief Technology Officer and co-founder of Bio-Tissue, Inc., a TissueTech company, shared insights with underrepresented undergraduates and medical students about the rewards and opportunities of […]

Amniox Medical Announces Publication of Phase 2 Clinical Trial Results Utilizing NEOX® CORD 1K (Trial Code Name: TTAX01) in Wound Repair and Regeneration

Amniox Medical

Data demonstrates 60 percent of wounds achieved complete wound closure, which is compatible with the healing rates observed in previous NEOX Cord 1K retrospective studies. Miami, FL – October 10, 2019 – Miami, FL – October 10, 2019 – Amniox® Medical, Inc. (Amniox), a TissueTechTM, Inc. company and leader in the clinical application of amniotic […]

TissueTech Names New Vice President to Lead Human Resources Operations and Process Improvement Initiatives

TissueTech

Human Birth Tissue Manufacturer is Scaling Up to Transition into a Biologics Provider Miami, FL – October 2, 2019 – TissueTech,TM Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, today announced the appointment of Kim Tripodo to the role of Vice President of Human Resources. In […]

TissueTech Names New Vice President to Oversee Scale Up of Product Lifecycle Management and Technology Transfer Activities

TissueTech

Human Birth Tissue Manufacturer Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 23, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Jerry Chang, PhD to the position of Vice President […]

Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percent

Bio-Tissue

Organization Prepares for Submission of Investigational New Drug Applications and Transition into a Biologics Provider Miami, FL – September 11, 2019 – Bio-Tissue®, Inc., a TissueTech,TM Inc. company, and pioneer and market leader in the development and clinical application of Cryopreserved Amniotic Membrane (CAM) products for ocular surface disease and injury, today announced the expansion […]

TissueTech Appoints New Vice President to Drive Quality Assurance Strategy for all Product Development and Manufacturing Activities

TissueTech

Manufacturer of Human Birth Tissue Products Ramps Up Workflow Processes as it Transitions into a Biologics Provider Miami, FL – September 5, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Sherry Saurini to the position of Vice President of Quality […]

TissueTech Expands its Clinical Program with Medidata’s End-to-end Unified Platform

TissueTech

Medidata Rave Clinical Cloud™ to help spearhead the company’s biologics transformation Unified platform creates a single source of truth for all data, enabling teams to focus on critical oversight activities, site satisfaction and improved patient experiences Miami, Fla. – July 3, 2019 – Medidata announced that TissueTech, Inc.. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform […]

TissueTech Raises $82 million in latest round of equity financing

TissueTech

Miami, Fla. – June 26, 2019 – TissueTech, Inc., the pioneer in regenerative medicine utilizing human umbilical cord and amniotic membrane, today announced the closing of an $82.25 million round of Preferred C equity financing led by EW Healthcare Partners (formerly Essex Woodlands) and followed by the third round of continuous investments from Ballast Point […]

Dr. Mark S. Milner to Present on Cryopreserved Amniotic Membrane at 2019 American Society of Cataract and Refractive Surgery (ASCRS)

Bio-Tissue

Miami, Fla. – May 2, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and the market leader in the clinical application of cryopreserved amniotic membrane-based products for the treatment of diseases and disorders of the ocular surface, today announced that Mark S. Milner, M.D., FACS, Associate Clinical Professor at Yale University Medical School and Co-founder […]

Archives

  • 2020
  • 2019
  • 2018